Literature DB >> 3494848

Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis.

V A Danis, L M March, D S Nelson, P M Brooks.   

Abstract

Blood monocytes and synovial fluid and tissue macrophages were examined for their ability to produce interleukin-1 (IL-1) measured in a mouse thymocyte proliferation assay. Spontaneous production of IL-1 by monocytes from patients with rheumatoid arthritis (RA) or ankylosing spondylitis was higher than that by cells from normal subjects, patients with osteoarthritis or patients with RA treated with gold. IL-1 production in response to LPS stimulation was similar in all groups. Spontaneous IL-1 production by synovial fluid macrophages from patients with RA was similar to that of their monocytes, but the response to LPS was smaller. Synovial tissue macrophages produced little IL-1. Similar results were obtained in assays of fibroblast proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494848

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis.

Authors:  V A Danis; A J Kulesz; D S Nelson; P M Brooks
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Modulation of the IL-1 content by anti-inflammatory drugs during an acute non-specific inflammation.

Authors:  I Paegelow; H Werner
Journal:  Agents Actions       Date:  1989-01

3.  Cytokine regulation of human monocyte interleukin-1 (IL-1) production in vitro. Enhancement of IL-1 production by interferon (IFN) gamma, tumour necrosis factor-alpha, IL-2 and IL-1, and inhibition by IFN-alpha.

Authors:  V A Danis; A J Kulesz; D S Nelson; P M Brooks
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

4.  The effect of gold treatment on monocyte interleukin-1 production in rheumatoid arthritis. A prospective study.

Authors:  V A Danis; A J Kulesz; D E Kelly; D S Nelson; P M Brooks
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid.

Authors:  A Bendrups; A Hilton; A Meager; J A Hamilton
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation.

Authors:  A A van de Loo; W B van den Berg
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

7.  Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.

Authors:  V A Danis; M Millington; V J Hyland; D Grennan
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

8.  Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study.

Authors:  A L Tan; H Marzo-Ortega; P O'Connor; A Fraser; P Emery; D McGonagle
Journal:  Ann Rheum Dis       Date:  2004-04-05       Impact factor: 19.103

9.  Systemic injection of group A streptococcal peptidoglycan-polysaccharide complexes elicits persistent neutrophilia and monocytosis associated with polyarthritis in rats.

Authors:  A F Wells; J A Hightower; C Parks; E Kufoy; A Fox
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.

Authors:  R Pacifici; L Rifas; R McCracken; I Vered; C McMurtry; L V Avioli; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.